American Trust Abbott Laboratories Transaction History

American Trust

$1.15 Billion
Q3 2024

A detailed history of American Trust transactions in Abbott Laboratories stock. As of the latest transaction made, American Trust holds 30,491 shares of ABT stock, worth $3.49 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

30,491

Previous 33,938 10.16%

Holding current value

$3.49 Million

Previous $3.53 Million 1.42%

% of portfolio

0.3%

Previous 0.3%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 29, 2024	SELL	$100.07 - $118.13 $344,941 - $407,194	-3,447 Reduced 10.16%	30,491 $3.48 Million
Q2 2024 Sep 11, 2024	SELL	$100.73 - $112.44 $163,081 - $182,040	-1,619 Reduced 4.55%	33,938 $3.53 Million
Q1 2024 Jun 11, 2024	SELL	$109.52 - $120.96 $62,316 - $68,826	-569 Reduced 1.58%	35,557 $4.04 Million
Q4 2023 Feb 21, 2024	SELL	$90.19 - $110.4 $63,674 - $77,942	-706 Reduced 1.92%	36,126 $3.98 Million
Q3 2023 Nov 15, 2023	BUY	$95.53 - $114.62 $332,730 - $399,221	3,483 Added 10.44%	36,832 $3.57 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $25,698 - $28,633	-255 Reduced 0.76%	33,349 $3.64 Million
Q1 2023 May 22, 2023	BUY	$96.86 - $114.01 $101,703 - $119,710	1,050 Added 3.23%	33,604 $3.4 Million
Q4 2022 Feb 16, 2023	SELL	$95.06 - $111.52 $70,249 - $82,413	-739 Reduced 2.22%	32,554 $3.57 Million
Q3 2022 Dec 02, 2022	BUY	$96.76 - $112.03 $72,473 - $83,910	749 Added 2.3%	33,293 $3.22 Million
Q2 2022 Oct 03, 2022	SELL	$102.07 - $123.37 $332,952 - $402,432	-3,262 Reduced 9.11%	32,544 $3.54 Million
Q1 2022 Jun 08, 2022	SELL	$114.02 - $139.04 $45,722 - $55,755	-401 Reduced 1.11%	35,806 $4.24 Million
Q4 2021 Mar 17, 2022	BUY	$115.53 - $141.46 $4.18 Million - $5.12 Million	36,207 New	36,207 $5.1 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

News

Stay updated on American Trust with notifications on news.

Account